Cargando…
Sprouty1, a new target of the angiostatic agent 16K prolactin, negatively regulates angiogenesis
BACKGROUND: Disorganized angiogenesis is associated with several pathologies, including cancer. The identification of new genes that control tumor neovascularization can provide novel insights for future anti-cancer therapies. Sprouty1 (SPRY1), an inhibitor of the MAPK pathway, might be one of these...
Autores principales: | Sabatel, Céline, Cornet, Anne M, Tabruyn, Sébastien P, Malvaux, Ludovic, Castermans, Karolien, Martial, Joseph A, Struman, Ingrid |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2944818/ https://www.ncbi.nlm.nih.gov/pubmed/20813052 http://dx.doi.org/10.1186/1476-4598-9-231 |
Ejemplares similares
-
The Antiangiogenic 16K Prolactin Impairs Functional Tumor Neovascularization by Inhibiting Vessel Maturation
por: Nguyen, Ngoc-Quynh-Nhu, et al.
Publicado: (2011) -
NF-κB: a new player in angiostatic therapy
por: Tabruyn, Sebastien P., et al.
Publicado: (2008) -
MicroRNA-21 Exhibits Antiangiogenic Function by Targeting RhoB Expression in Endothelial Cells
por: Sabatel, Céline, et al.
Publicado: (2011) -
Renal Biomarker and Angiostatic Mediator? Cystatin C as a Negative Regulator of Vascular Endothelial Cell Homeostasis and Angiogenesis
por: Benndorf, Ralf A.
Publicado: (2018) -
Cosuppression of Sprouty and Sprouty-Related Negative Regulators of FGF Signalling in Prostate Cancer: A Working Hypothesis
por: Assinder, Stephen J., et al.
Publicado: (2015)